Score Overview
Explore the 2021 public Archive ranking →
Merck & Company Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 41.51B to $ 64.92B and net income grew from $ 7.06B to $ 18.25B. Revenue increased in every one of those 5 years; net income in 3.
Across Merck & Company Inc's full reported history, from 1985 to 2025, revenue grew from $ 3.54B to $ 64.92B and net income grew from $ 539M to $ 18.25B. Revenue increased in 80% of the years measured; net income in 61%.
Merck & Company Inc currently holds a 20-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-01 | $ 149.86 | — |
1 Year2025-08-29 | $ 81.40 | 84.11% |
5 Years2021-09-01 | $ 65.18 | 129.92% |
10 Years2016-09-01 | $ 44.16 | 239.33% |
20 Years2006-09-01 | $ 19.64 | 7x |
30 Years1996-08-30 | $ 11.35 | 13x |
All Time1978-01-13 | $ 0.32 | 472x |
| Period | Last Price2026-09-01 | 1 Year2025-08-29 | 5 Years2021-09-01 | 10 Years2016-09-01 | 20 Years2006-09-01 | 30 Years1996-08-30 | All Time1978-01-13 |
|---|---|---|---|---|---|---|---|
| Price | $ 149.86 | $ 81.40 | $ 65.18 | $ 44.16 | $ 19.64 | $ 11.35 | $ 0.32 |
| Return | — | 84.11% | 129.92% | 239.33% | 7x | 13x | 472x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 66.40B | $ 3.17B | $ 7.14B |
| 2025 | $ 64.92B | $ 18.25B | $ 14.56B |
| 2024 | $ 64.16B | $ 17.11B | $ 13.68B |
| 2023 | $ 60.11B | $ 365M | $ 7.09B |
| 2022 | $ 59.28B | $ 14.51B | $ 13.19B |
| 2021 | $ 48.70B | $ 13.04B | $ 8.09B |
| 2020 | $ 41.51B | $ 7.06B | $ 8.05B |
| 2019 | $ 39.12B | $ 9.84B | $ 10.45B |
| 2018 | $ 42.29B | $ 6.22B | $ 8.86B |
| 2017 | $ 40.12B | $ 2.39B | $ 8.49B |
| 2016 | $ 39.80B | $ 3.92B | $ 14.34B |
| 2015 | $ 39.49B | $ 4.44B | $ 13.42B |
| 2014 | $ 42.23B | $ 11.92B | $ 15.71B |
| 2013 | $ 44.03B | $ 4.40B | $ 17.48B |
| 2012 | $ 47.26B | $ 6.16B | $ 16.14B |
| 2011 | $ 48.04B | $ 6.27B | $ 14.97B |
| 2010 | $ 45.98B | $ 861M | $ 12.20B |
| 2009 | $ 27.42B | $ 12.89B | $ 9.60B |
| 2008 | $ 23.85B | $ 7.80B | $ 5.48B |
| 2007 | $ 24.19B | $ 3.27B | $ 8.23B |
| 2006 | $ 22.63B | $ 4.43B | $ 8.71B |
| 2005 | $ 22.01B | $ 4.63B | $ 15.63B |
| 2004 | $ 22.97B | $ 5.83B | $ 7.08B |
| 2003 | $ 22.48B | $ 6.83B | $ 4.17B |
| 2002 | $ 21.44B | $ 7.14B | $ 4.97B |
| 2001 | $ 21.19B | $ 7.28B | $ 3.28B |
| 2000 | $ 40.36B | $ 6.82B | $ 4.25B |
| 1999 | $ 32.71B | $ 5.89B | $ 3.20B |
| 1998 | $ 26.89B | $ 5.24B | $ 2.60B |
| 1997 | $ 23.63B | $ 4.61B | $ 1.12B |
| 1996 | $ 19.82B | $ 3.88B | $ 1.35B |
| 1995 | $ 16.68B | $ 3.33B | $ 1.84B |
| 1994 | $ 14.96B | $ 2.99B | $ 1.60B |
| 1993 | $ 10.49B | $ 2.16B | $ 829M |
| 1992 | $ 9.66B | $ 1.98B | $ 575M |
| 1991 | $ 8.60B | $ 2.12B | $ 797M |
| 1990 | $ 7.67B | $ 1.78B | $ 806M |
| 1989 | $ 6.55B | $ 1.49B | $ 685M |
| 1988 | $ 5.93B | $ 1.20B | $ 1.55B |
| 1987 | $ 5.06B | $ 906M | $ 1.14B |
| 1986 | $ 4.12B | $ 675M | $ 965M |
| 1985 | $ 3.54B | $ 539M | $ 842M |
Where Merck & Company Inc has ranked, year by year
Each point is that year's ranking on ten years of fundamentals, as a share of every company we could rank at the time. Higher is better. We show the share rather than the place because the number of companies grows — 193 in 1996, 2,060 in 2021 — so the same place means something different at either end.
Reached the top 50 on HDB Score in 6 years, the longest run being 6 in a row — but not in 2021.
1996: 2.6% · 2021: 52.1% · free through 2021 · longest runs
See where MRK ranks today
You're looking at Merck & Company Inc's public company record. Membership adds the current comparative layer and continues its ranking history through recent years.
- Current market-wide rankings across 3,839 covered companies
- See where Merck & Company Inc ranks today
- Complete current Score Views across every period
- Current Tenure and recent Archive years
- Portfolio and member features
$99/year $149 founding price
Become a Member30-day money-back guarantee.
